Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald John TrumpTrump rips Dems' demands, impeachment talk: 'Witch Hunt continues!' Nevada Senate passes bill that would give Electoral College votes to winner of national popular vote The Hill's Morning Report - Pelosi remains firm despite new impeachment push MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinRichard (Dick) Joseph DurbinIraq War looms over Trump battle with Iran Muslim lawmakers host Ramadan iftar to break fast at Capitol Let's stop treating student borrowers like second-class citizens MORE (D-Ill.), Kirsten GillibrandKirsten Elizabeth GillibrandGOP faces new challenge in 2020 abortion fight 2020 Dems break political taboos by endorsing litmus tests Biden says Congress must move to protect abortion rights MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanOvernight Health Care — Presented by Campaign for Accountability — House passes drug pricing bills amid ObamaCare row | Senate Republicans running away from Alabama abortion law | Ocasio-Cortez confronts CEO over K drug price tag Bipartisan senators unveil measure to end surprise medical bills Work on surprise medical bills goes into overdrive MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownOn The Money: Judge upholds House subpoena for Trump financial records | Trump vows to appeal ruling by 'Obama-appointed judge' | Canada, Mexico lift retaliatory tariffs on US | IRS audit rate falls Lawmakers grapple with the future of America's workforce The Hill's Morning Report - Presented by Pass USMCA Coalition - Restrictive state abortion laws ignite fiery 2020 debate MORE (D-Ohio) and Angus KingAngus Stanley KingSenate panel approves Interior nominee over objections from Democrats Trump, Europe increasingly at odds on Iran The Hill's 12:30 Report: Dems raise stakes with talk of 'constitutional crisis' MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.